Voisin Consulting Life Sciences office page icon

Drug Development Program

Target Product Profile: Definition of the key features of your product to build your industrial development roadmap.

Regulatory Landscape: Build the interaction plan and strategy of communication with EMA & FDA.

Nonclinical Development: Choose the right model for your evidence based strategy.

Clinical Plan:  The backbone of your entire development plan.

CMC Accelerated Development: Help in achieving a scale up of your production method.

Access to Market:  Identify the target population & price potential.

Small Molecules Option

Strategic help on: sub-contract interactions and technical challenges.

Biologics Option

New innovative processes exist to develop and bring small molecules into the market, such as setting up Clinical Trials “in silico”, evolving validation strategies for accelerated production method.


Post thumbnail Carlo Chiavaroli, PhD

Carlo Chiavaroli, PhD

Senior Director, Nonclinical & Early Clinical Development

Post thumbnail Mark Gauthier

Mark Gauthier

Senior Director, Regulatory Science, Drugs & Biologics

Thérèse Croughs thumbnail

Thérèse Croughs

Global Medical and Regulatory Development Strategy and Head of Market Access

Post thumbnail Private: Véronique Gelebart, M.Sc.

Private: Véronique Gelebart, M.Sc.

Global Head of Clinical Research

Post thumbnail Valérie Arnaudinaud-Lignier, PhD

Valérie Arnaudinaud-Lignier, PhD

Director, CMC & Quality

Post thumbnail Lise Merlay Barbin PhD, Eng.

Lise Merlay Barbin PhD, Eng.

Senior Director, Regulatory Science

Post thumbnail Zoran Simic, MD, MSc, FFPM, MRCPsych, IFAPA

Zoran Simic, MD, MSc, FFPM, MRCPsych, IFAPA

Medical Director

Post thumbnail Gabrielle Nayroles, M.Sc.

Gabrielle Nayroles, M.Sc.

Director, Market Access


bioadhesive ophtalmics

Meet your new neighbors

We'd love to get to know you

Join us, we offer you an extraordinary chance to learn, to develop and to be part of an exciting experience and team.

Tell us your story